Related Experiment Video
Updated: Jul 18, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Mechanisms of disease: apoptosis in heart failure--seeing hope in death
Jagat Narula1, Nezam Haider, Eloisa Arbustini
1Division of Cardiology, University of California, Irvine School of Medicine, 101 The City Drive, Building 53, Mail Route 81, Orange, CA 92868, USA. narula@uci.edu
Abstract:
Apoptosis or programmed cell death is an evolutionarily conserved process of cell death, wherein cells die without provoking significant inflammatory response. There is convincing evidence that apoptosis contributes to the progression of heart failure. Apoptosis occurs through a cascade of subcellular events including cytochrome c release into the cytoplasm and activation of proteolytic caspases. Activated caspases lead to fragmentation of cytoplasmic proteins, including contractile apparatus, to a variable extent. It is proposed that the release of cytochrome c from mitochondria and contractile protein loss in living heart muscle cells contributes to systolic dysfunction. Interestingly, despite extensive changes in the cytoplasm, nuclear damage, which is the final event in apoptosis, is rather infrequent in the failing heart. Since the nucleus remains unaffected and the genetic blueprint intact in cells with interrupted apoptosis, these heart muscle cells might be amenable to cytoplasmic reconstitution. This process of 'apoptosis interruptus' could allow development of novel strategies to reverse or attenuate heart failure.
Insights
Apoptosis contributes to heart failure by damaging heart muscle cells. Interrupting this programmed cell death may offer new ways to treat heart failure by restoring cell function.
Area of Science:
- Cardiology
- Cell Biology
- Molecular Biology
Background:
- Apoptosis, or programmed cell death, is a conserved cellular process.
- Apoptosis is implicated in the progression of heart failure.
- Key events include cytochrome c release and caspase activation, leading to cytoplasmic damage.
Purpose of the Study:
- To explore the role of apoptosis in heart failure.
- To investigate the potential for interrupting apoptosis to treat heart failure.
Main Methods:
- Review of existing evidence on apoptosis in heart failure.
- Analysis of subcellular events in apoptotic heart muscle cells.
Main Results:
- Apoptosis contributes to systolic dysfunction through contractile protein loss.
- Nuclear damage is infrequent in failing heart cells undergoing apoptosis.
- Intact nuclei suggest potential for cellular repair.
Conclusions:
- Interrupted apoptosis ('apoptosis interruptus') may be a therapeutic target.
- Restoring cytoplasmic function in heart cells could reverse or attenuate heart failure.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Apoptosis
Heart Failure I: Introduction
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Heart Failure V: Medical Management